Across TCGA pan-cancer cohorts, MIR548AI RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MIR548AI data layer.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher MIR548AI RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR548AI expression acts as an unfavorable survival marker.
KIRP, KIRC, and ESCA are the cancer types where MIR548AI RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.